FDA Approved Medical Products for:

Congenital generalized lipodystrophy type 2

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name metreleptin
Trade Name
(Manufacturer Name)
Myalept
(Amylin Pharmaceuticals, LLC)
Indication
The FDA has approved this product to be used in this manner.
Adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
More Information about this product Drug Information Portal